Objective Systematic reviews of randomized controlled trials (RCTs) support the efficacy of psychological interventions for procedural pain management. However, methodological limitations (e.g., inadequate randomization) have affected the quality of this research, thereby weakening RCT findings. Methods Detailed quality coding was conducted on 28 RCTs included in a systematic review of psychological interventions for pediatric procedural pain. Results The majority of RCTs were of poor to low quality (criteria reported in <50% of RCTs). Commonly reported criteria addressed study background, conditions, statistical analyses, and interpretation of results. Commonly nonreported criteria included treatment administration, evaluation of treatment efficacy (effect sizes, summary statistics, intention-to-treat analyses), caregiver demographics, follow-up, and participant flow. Quality was greater in more recent trials, and did not vary by journal type (psychology vs. medical). Conclusion Despite poor quality ratings, quality reporting in psychological RCTs for pediatric procedural pain has improved over time. Recommendations for quality enhancement are provided.
Medical procedures involving needles are a considerable source of pain and anxiety for children and adolescents (e.g., Broome, Bates, Lillis, & McGahee, 1990) . A wide variety of psychological interventions (e.g., distraction, relaxation) are available to help manage procedural pain and anxiety. A comprehensive systematic review investigated the efficacy of psychological interventions for managing procedural pain and distress in children and adolescents, to determine which interventions had the most empirical support (Uman, Chambers, McGrath, & Kisely, 2006 . The review included 28 randomized controlled trials (RCTs) involving 1951 participants. The interventions with the strongest effect sizes were distraction, hypnosis, and cognitive-behavioral interventions. However, a significant concern identified in this review was the generally poor quality of the trials in this area.
Although there is no standard definition for study 'quality', it generally refers to the methodology of a study (usually an RCT), including whether it has sufficient internal validity, addresses the generalizability of findings, provides adequate study details, and adheres to strong study implementation, design, and analyses. Poor quality trials limit our understanding of whether an intervention is efficacious, as poor study designs and implementation can lead to spurious findings (either supporting or failing to support the intervention). There are various quality rating scales available; however, some of the most commonly used measures were developed for assessing RCTs evaluating pharmacological interventions (e.g., Jadad et al., 1996) . This is an important distinction because many quality criteria relevant for pharmacological interventions (e.g., double-blinding), are not feasible or appropriate for psychological interventions which typically do not have obvious 'placebo' equivalents. Because wait-list or notreatment control conditions come with their own limitations, the selection of appropriate 'real world' comparison groups remains an important challenge for evaluating psychological interventions (Palermo, 2009) . To illustrate, the systematic review described above (Uman et al., 2006 (Uman et al., , 2008 employed the commonly used 5-point Oxford Quality Rating scale for evaluating the quality of the 28 included RCTs (Jadad et al., 1996) . Results demonstrated poor quality levels, with the majority of the RCTs (16/28) receiving scores of zero. However, this scale is limited by the fact that it includes only five criteria and has a strong focus on double-blinding. In order to provide a meaningful quality assessment, it is necessary to use a more comprehensive set of quality criteria that are relevant for trials examining psychological interventions.
The most widely adopted criteria currently used to evaluate the quality of RCTs are the Consolidated Standards of Reporting Trials (i.e., CONSORT Statement; Altman et al., 2001; Begg et al., 1996) . The CONSORT Statement is comprised of 22 criteria and an accompanying flow-diagram to track the number of participants through each stage of the trial. An additional set of five quality criteria have been recommended by the Evidence-Based Behavioral Medicine (EBBM) Committee of the Society of Behavioral Medicine (e.g., training and supervision of treatment providers) as an adjunct to the CONSORT Statement, although they have not yet been formally adopted as part of the CONSORT . Most recently, the CONSORT group published an extension to the revised 2001 CONSORT Statement, in which they provide additional information for half of the original criteria (11/22), making them more appropriate for assessing nonpharmacological trials (Boutron et al., 2008) .
Despite the CONSORT Statement being adopted as recommended criteria by many biomedical journals; psychology journals have been slower to adopt these criteria for psychological or nonpharmacological intervention trials (Stinson, McGrath, & Yamada, 2003) . In an attempt to discover how well RCTs in psychological journals adhered to the CONSORT criteria, Stinson and colleagues (2003) compared trials published in the Journal of Pediatric Psychology ( JPP) with trials published in the Journal of Clinical and Consulting Psychology ( JCCP). They found the numbers of CONSORT criteria not reported in both journals were very similar, with half (11/22) of the criteria reported less than 25% of the time. Similarly, in a quality study of RCTs in leading medical journals, reporting of many CONSORT criteria remained suboptimal (Mills, Wu, Gagnier, & Devereaux, 2005) . Another study examining the analytic quality of behavioral health RCTs, found that while overall quality scores were poor, reporting omissions were more profound in RCTs published in psychology journals than medical journals (Spring, Pagoto, Knatterud, Kozak, & Hedeker, 2007) .
In a commentary accompanying the study by Stinson et al. (2003) , the adoption of the CONSORT Statement when conducting/reporting RCTs investigating psychological interventions was promoted, and it was recommended that JPP adopt the CONSORT Statement as a way of improving the evidence base in pediatric psychology (McGrath, Stinson, & Davidson, 2003) . Since this time, JPP has created an ''Authors' Checklist for Manuscript Submission to JPP'', which advocates that the CONSORT Statement be adhered to when submitting RCTs for publication (http://www.oxfordjournals.org/ our_journals/jpepsy/for_authors). However, it is important to note that even if studies claim to have consulted the CONSORT Statement, this does not ensure they have appropriately addressed all criteria.
Since the publication of the CONSORT Statement, additional quality measures have been developed. For example, Yates and colleagues developed and validated a 13-criteria (or 26 sub-criteria) measure to assess the quality of psychological interventions for pain management (Yates, Morley, Eccleston, & Williams, 2005) . While there is some overlap across the criteria included in this scale and previous quality measures (e.g., CONSORT, EBBM) this quality rating scale addresses additional methodological areas that are relevant for psychological intervention trials (e.g., validity/reliability of outcomes, using a well-matched control group). These areas are particularly relevant to the field of pediatric pain management as there is a plethora of available assessment measures, and comparison groups need to control for various nonspecific treatment components (e.g., caregiver presence/involvement). This measure by Yates and colleagues (2005) also differs from other measures by allowing for differential weighing of items (e.g., on a 0-1 or 0-2 scale).
In addition, regularly assessing the quality of RCTs is important for determining whether quality reporting has improved since the development of guidelines such as the CONSORT Statement, and to identify areas in need of further improvement. A study evaluating the reporting of methodological information in four journals of pediatric and child psychology found that although overall quality scores were low, improvements in the reporting of quality in more recently published trials were noted (Raad, Bellinger, McCormick, Roberts, & Steele, 2008) . Thus, in order to improve the quality of psychological trials, it is essential to determine which quality criteria are most commonly addressed and/or omitted in RCTs of psychological interventions, and evaluate quality over time.
The objective of this study was to conduct a comprehensive evaluation of the quality of the RCTs identified in the aforementioned systematic review on psychological interventions for pain management (Uman et al., 2006 (Uman et al., , 2008 , with the aim of isolating specific areas where trials need improvement, and making corresponding recommendations. We were also interested in whether the quality of trials in this area varied as a function of publication year or journal type. Based on previous studies examining the quality of RCTs in psychology, it was hypothesized that: (1) quality reporting would be suboptimal (i.e., quality criteria addressed in 50% of trials); (2) there would be a positive relationship between quality reporting and publication year, with greater quality reporting in more recently published trials; and (3) quality reporting would be greater in medical/nursing journals compared to psychological/behavioral journals. While we purposefully chose RCTs in the area of psychological interventions for pediatric procedural pain to conduct this detailed quality analysis, it was our hope that this work could be used as an illustrative example for other areas of study in pediatric psychology.
Methods

Trials and Participants
Twenty-eight RCTs were identified in the aforementioned Cochrane review of psychological interventions for needlerelated procedural pain in children and adolescents 2-19 years of age (Uman et al., 2006 (Uman et al., , 2008 . Of these 28 RCTs, three were unpublished doctoral dissertations. Each study included one or more of the following needle procedures: immunization (n ¼ 9), venipuncture (n ¼ 8), lumbar puncture (n ¼ 5), IV insertion (n ¼ 4), bone marrow aspiration (n ¼ 3), and intramuscular injection (n ¼ 1). The diagnostic condition of the study participants included: healthy children (n ¼ 15), oncology patients (n ¼ 9), patients undergoing medical evaluation (n ¼ 4), and other medical conditions (n ¼ 2). Various psychological interventions were evaluated in the RCTs, with the most common interventions being distraction (n ¼ 11), CBT (n ¼ 6), and hypnosis (n ¼ 5). For further details regarding trial characteristics, please see Uman et al. (2006 Uman et al. ( , 2008 .
Quality Assessment
A comprehensive set of quality criteria for evaluating RCTs examining psychological interventions for procedural pain was compiled using criteria from the following validated quality measures/guidelines: (a) the revised CONSORT Statement (Altman et al., 2001) ; (b) the EBBM criteria proposed as an amendment to the CONSORT Statement ; and (c) the quality rating scale developed for psychological trials for pain (Yates et al., 2005) . Although there is no official name for this latter scale, for simplicity we will refer to it using the acronym QRS (for 'quality rating scale'). The current study used the 2001 CONSORT Statement rather than the 2008 extension, as the latter was published after the data coding for this study was completed. However, by developing the list of quality items in this study to be specifically relevant for psychological intervention trials, we were able to achieve a similar goal as the 2008 CONSORT extension which adapted the items for nonpharmacological interventions.
The comprehensive list of criteria outlined in this study was generated in order to: (1) select criteria that were relevant for evaluating trials of psychological interventions for pain management; (2) reduce criterion overlap by combining common themes across the various published scales into one set of quality criteria; (3) include additional criteria not addressed in these measures that were specifically relevant to pediatric pain interventions (e.g., criteria addressing behavioral measures of pain and distress); and (4) create a simple dichotomous coding scheme to allow for comparability between criteria given that various measures use discrepant evaluation systems (e.g., yes/no, numerical ratings). Many criteria from the aforementioned published measures/scales include several components within each quality criterion and lack specific operational definitions. As a result, we operationalized and broke down quality criteria so that each one assessed only one distinct and well-defined component.
A list of quality criteria was compiled by the lead author (L.U.) and reviewed by all co-authors, and a list of 62 criteria was derived by consensus. These criteria were reviewed by a panel of nine experts in the area of pediatric pain who rated each criterion on clarity, relevance, and whether it could be easily coded dichotomously (i.e., criteria met vs. criteria not met). This feedback was then used to clarify wording, add additional criteria, and remove criteria not relevant or important to study quality. Based on this feedback, one criterion (i.e., identifying statistical program/software) was dropped from the list because of low relevance ratings. Seven criteria in the form of questions (identified by a 'q' following the item number), were added to clarify whether criteria were relevant for a particular study. For example, for criterion 13, we added a question (13q: ''Did the study include a follow-up period?'') prior to the main criterion (13: ''If yes to 13q, time period for data collection is stated''). As shown in Table I , the final list of quality criteria at IWK Grace Health Centre on July 22, 2010 All of the RCTs in the Cochrane review were then coded on each of the 70 quality criteria by one of the study co-authors (K.H.). Twenty percent of the RCTs were randomly selected and coded independently by the lead author (L.U.) to establish interrater reliability using Kappa coefficients. Coders were not blind to study authors or treatment outcomes. Furthermore, for the purpose of this study, we operationalized the following four-category scoring system based on the percentage of RCTs meeting each quality criterion: poor quality (0-25%), low quality (26-50%), fair quality (51-75%), and good quality (76-100%). The decision for scores 50% to fall into the poor/low ranges was based on findings from the previously described study by Stinson and colleagues (2003) , who found that 50% of the trials they evaluated met fewer than half of the CONSORT Statement criteria. We used parametric statistics except for the analysis of quality item scores, as we could not assume that the quality criteria had an underlying interval scale or normal distribution. When analyzing quality item scores, we used nonparametric statistics (Spearman's rank-order correlations, Mann-Whitney U-tests).
Results
Interrater reliability assessed for 20% of the trials yielded a Kappa coefficient of 0.80. The total number and percentage of RCTs reporting each quality criterion is provided in Table I . Unless otherwise indicated, all values in the tables are calculated based on the 28 RCTs. Table I also indicates whether each quality item was based on criteria from an existing measure or guideline (e.g., CONSORT, EBBM, QRS). Of the 70 criteria evaluated, 31 (44.29%) produced quality scores in the poor range (i.e., addressed in 0-25% of RCTs), 10 (14.29%) in the low range (i.e., addressed in 26-50% of RCTs), 13 (18.57%) in the fair range (i.e., addressed in 51-75% of RCTs), and 16 (22.86%) in the good range (i.e., addressed in 76-100% of RCTs).
Criteria falling under the same general themes were grouped together, resulting in 14 categories of unequal criterion sizes. For each category, we also calculated the mean percentage of RCTs meeting all criteria in the category, although it should be noted that there was a broad range of values for the percentage of RCTs meeting each individual criterion in the categories (see Table I ). Based on these mean percentages, the majority of categories fell in the poor (n ¼ 6) and fair (n ¼ 6) ranges, with only two categories falling in the low (n ¼ 1) and good (n ¼ 1) ranges. Categories falling in the poor range reflect trials failing to fully address the following study areas: (a) randomization (M% ¼ 22.6, range ¼ 0. In order to determine whether the quality ratings of RCTs improved as a function of publication year, we ran two complementary analyses. The first analyses (Spearman rank order correlations) were conducted to address whether quality scores improved over time, and the second analyses (Mann-Whitney U-tests) were more specifically intended to address whether RCTs published pre-CONSORT differed from those published post-CONSORT. First, Spearman correlations were conducted between publication year and summary quality scores for each of the 14 categories described above. Publication years for the RCTs ranged from 1981 to 2006, and summary quality scores for each RCT were calculated by summing the item scores for all items in that category. For example, the first category (Randomization) is comprised of items 1, 2, and 3. If an RCT reported the information for item 1 (1 point), item 2 (1 point), but not item 3 (0 points), the RCT's summary score for that category would be 2 (1 þ 1 þ 0), out of a possible 3 points. Thus, each category summary score can range from 0 (i.e., none of the items reported) to X, where X represents the number of items in that category. The correlations between publication year and the summary quality scores were nonsignificant (r s ¼ -.43 to. 32) for all categories with the exception of 'Sample Characteristics' (r s ¼ .53, p ¼ .004). In addition, we used publication year to divide the RCTs into two groups comparing those published before the CONSORT Statement in 1996 (n ¼ 10) versus those published after the CONSORT Statement (n ¼ 18). A series of Mann-Whitney U-tests using summary scores for each of the 14 categories found no significant differences between pre-and post-CONSORT scores for any categories (p ¼ .12-.87), with the exception of 'Sample Characteristics' where the post-CONSORT score (median ¼ 3, range ¼ 1-5) was significantly greater than the pre-CONSORT score (median ¼ 2,
To examine whether the quality of trials has improved with time, we also compared publication year with total scores for all CONSORT items (n ¼ 22) þ EBBM items (n ¼ 5), as well as total scores for the 26 QRS items, given that these are validated measures/guidelines upon which our list of criteria was based. The CONSORT and EBBM items were each scored as 0 (not reported) or 1 (reported), and then summed together for a possible total score range of 0-27. Since each QRS item is coded on a 0-1 or 0-2 scale, the QRS total score was obtained by summing each item score for a total score range of 0-36. A significant positive correlation was found for the QRS (r s ¼ .40, p ¼ .04), and a marginally nonsignificant positive correlation was found for the CONSORT þ EBBM items (r s ¼ .38, p ¼ .05). When using the CONSORT þ EBBM total scores as the outcome, RCTs published post-CONSORT (median ¼ 10, range ¼ 8-15) were significantly greater than those published pre-CONSORT (median ¼ 8, range ¼ 4-11), U ¼ 31.00, n 1 ¼ 10, n 2 ¼ 18, p ¼ .004, two-tailed. Similarly, using QRS scores as the outcome, RCTs published post-CONSORT (median ¼ 15, range ¼ 10-26) were significantly greater than those published pre-CONSORT (median ¼ 13, range ¼ 8-15), U ¼ 39.00, n 1 ¼ 10,
To examine differences in study quality as a function of journal type, we categorized all RCTs into those published in medical/nursing journals (n ¼ 12) versus those published in psychology/behavioral journals (n ¼ 13). No significant differences emerged for journal type, using total scores for the CONSORT þ EBBM (Medical journals: median ¼ 8.5, range ¼ 4-13; Psychology journals: median ¼ 11.0, range ¼ 5-15; U ¼ 53.00, n 1 ¼ 12, n 2 ¼ 13, p ¼ .19, twotailed) and total QRS scores (Medical journals: median ¼ 14.0, range ¼ 10-17; Psychology journals: median ¼ 15.0, range ¼ 8-26; U ¼ 52.50, n 1 ¼ 12, n 2 ¼ 13, p ¼ .17, twotailed). The three unpublished doctoral dissertations were excluded from these analyses, although results remained nonsignificant when they were included. 1 Lastly, a post-hoc analysis was conducted to examine whether quality score ratings for the 70 items were related to perceived item importance. The panel of nine experts who provided feedback were also asked to rate each item for importance (i.e., relevance) using a 0-4 Likert scale. A Pearson correlation between mean importance ratings and quality scores for each item (using the quality score % item ratings from Table I ) was significant (r ¼ .304, p ¼ .016).
Discussion
Overall, the results of this study supported our hypothesis that quality scores would be suboptimal, with over half of the 70 quality criteria (n ¼ 41, 58.6%) receiving poor to low quality ratings (i.e., being addressed in 50% or fewer RCTs). These results are consistent with the suboptimal findings from the aforementioned studies by Stinson et al. (2003) and Spring et al. (2007) . However, unlike the study by Spring and colleagues (2007) we did not find that quality scores were significantly lower in trials published in psychology journals compared to those published in medical journals. In fact, the quality scores in the psychology journals were greater, although these differences were nonsignificant.
On a positive note, we found some support for our hypothesis that quality scores would improve over time, particularly since the publication of the CONSORT Statement in 1996. Raad and colleagues (2008) found similar quality improvements over time in journals of pediatric and child psychology. Together, these findings are encouraging and suggest that the field of psychology is making important strides towards quality improvement when reporting psychological intervention trials for pediatric populations.
It is likely that some of the reasons for omitting various quality criteria may be due to the brief and straightforward nature of many psychological interventions. For example, items may not be addressed due a lack of awareness of their utility or purpose (e.g., intention-to-treat analyses, flow diagrams). Furthermore, given the relatively recent movement towards assessing study quality, 1 Although we included three unpublished dissertations in our analyses, our overall findings did not differ when these RCTs were excluded. Thus, to be consistent with the RCTs included in the original review (Uman et al., 2006 (Uman et al., , 2008 , we included the dissertations in all statistical analyses with the exception of those assessing the impact of journal type on quality scores.
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at IWK Grace Health Centre on July 22, 2010 researchers may lack training or awareness of the importance of quality assessment. Nevertheless, the responsibility for ensuring and reporting trial quality lies not just with the researcher, but also with journal reviewers and editors. Lastly, our post-hoc analysis indicated that item quality scores were significantly and positively correlated with expert-rated importance ratings. Although this analysis is limited (e.g., small sample size, non-anonymous ratings), the results suggest that items deemed to be more important or relevant were indeed those more likely to be reported in RCTs in this field. Future research aimed at improving quality reporting should therefore consider the importance and relative contribution of various quality dimensions when refining scales and making recommendations.
Despite providing a comprehensive overview of RCT quality, some important study limitations must be addressed. First, because there are no standard quality cut-off scores outlined in the literature, we created our own categorization system (poor, low, fair, good) in order to make sense of this large amount of data. However, these cut-offs are somewhat arbitrary and future research should aim to identify more objective and empirically supported classifications. Second, it can be argued that the criteria most commonly omitted in RCTs may be omitted because they are deemed less important than criteria more commonly reported. While we did not conduct an in-depth analysis of criteria importance, all of the final criteria were rated as important/relevant by the expert panel. Third, the fourteen categories we created were unequal in criterion size, and this should be taken into account when interpreting results. Lastly, although the current study used the 2001 CONSORT Statement rather than the 2008 extension, as outlined above, the comprehensive list of quality items used in this study was adapted for nonpharmacological interventions in a similar manner to the 2008 CONSORT extension. For example, our quality list and the 2008 CONSORT extension both expanded upon the original CONSORT criteria to create new items pertaining to study conditions (i.e., describing both the intervention and comparison groups), blinding (i.e., identifying whether those administering interventions were blind), and implementation (i.e., providing details regarding how treatment and comparison conditions were administered by treatment providers).
Several additional caveats should be kept in mind when interpreting the results of this study. First, it should be noted that quality scales and studies typically assess RCT reporting, rather than directly assessing RCTs (i.e., through direct involvement or author contact). Therefore, low quality scores do not necessarily reflect poorly conducted studies, but rather reflect omissions of information. Additionally, although the results of this study revealed suboptimal quality scores, it is likely that these results may actually represent an overestimate of quality in the field (i.e., higher quality scores than other studies), as these trials were those pre-selected as meeting the methodological criteria necessary for inclusion in the previously described systematic review (e.g., true randomization, validated outcome measures). These RCTs arguably represent those with the strongest quality reporting, as an additional 51 trials did not meet the criteria for inclusion in the original review (Uman et al., 2006 (Uman et al., , 2008 . This suggests that the quality of psychological intervention trials within the field of pediatric procedural pain may be even poorer than the subset of RCTs analyzed in this study. Lastly, while some items are more relevant to the field of pediatric pain (e.g., using observational measures), the majority of quality items assessed in this study can be applied to various psychological intervention trials within the field of pediatric psychology. Therefore, the trials assessed in this study could illustrate problems with quality reporting that may be present in trials in other areas of pediatric psychology.
Based on the results of this study, several recommendations for improving the reporting and conducting of psychological intervention RCTs in the area of pediatric procedural pain management are provided. The recommendations below are those based on criteria with the poorest quality scores (reported in 25% of trials).
Clearly Identify and Describe Randomization Procedures
In order to facilitate further systematic reviews and metaanalyses, authors should identify whether the study is an RCT in the study title or abstract. Our results indicated that only half of the studies identified themselves as RCTs in the study title or abstract, which makes it challenging to identify all RCTs in a given area using electronic databases. It is important for the randomization procedure(s) to be clearly described, particularly because the systematic review on which this study was based (Uman et al., 2006 (Uman et al., , 2008 indicated that many trials in this area are identified as 'randomized' when they actually used alternating (i.e., non-random) assignment.
Identify Time Periods for Data Collection and Follow-Up
Only 11% of RCTs identified the time period during which data collection was conducted. Given the often large timegaps between data collection and study publication, this information can have important implications for interpreting results (e.g., comparing them to up-to-date advances in knowledge and/or studies of the same cohort). In addition, only 7% of trials included a followup period. However, many treatments for medical procedures are intended for the procedure to which they are applied and are not intended to have carry-over benefits.
Provide Caregiver Demographics When Reporting Caregiver-Reported Outcomes
When caregivers provide key outcome information or ratings, it is important to provide information on caregiver demographics for each study condition or group. For example, factors such as parent gender, education, and socioeconomic status can have important implications and influences on study outcomes (e.g., if all fathers end up in the treatment condition and all mothers in the control condition). When caregiver demographics are the same as those of participants (i.e., children/adolescents) on a given dimension, this should be clearly identified.
Identify Participant Flow Through Each Stage of the Study
It is recommended that RCTs identify the flow (i.e., number of participants) in each stage of the treatment (e.g., assessed for eligibility, randomized, lost to followup, analyzed), with reasons for dropouts identified. The CONSORT Statement provides a very helpful flow diagram to track these values, although this information could also easily be addressed within the body of the paper. Our findings suggest that this is still an area in need of improvement, as only 1 of the 18 RCTs published post-CONSORT included a flow chart.
Develop Treatment Manuals or Clear Reporting of Treatment Administration Procedures
Treatment manuals are important for providing readers with detailed treatment descriptions, and therefore what was actually 'supported' by the research, which facilitates replication (Chambless et al., 1996) . Even with relatively straightforward interventions, in addition to describing the treatment being delivered, authors should also describe treatment administrator training, participant engagement in the treatment, and treatment fidelity (i.e., whether the treatment was delivered as intended). Our results found that only 2/28 (7.1%) of the RCTs described treatment administrator training and treatment fidelity, and only 6/28 (21.4%) evaluated participant engagement in treatment. Addressing participant engagement is particularly important when testing the effects of attention-redirecting coping strategies for pain management (e.g., distraction), as theories of limited attentional resources suggest that intervention efficacy depends on whether attention is allocated primarily to the strategy or the nociceptive input (Eccleston, 2005) . In addition, given that there can be wide variability within the same intervention (e.g., distraction), authors should explicitly describe the exact components of the intervention either in the form of a manual (available to readers upon request) or in the paper.
Include Effect Sizes, Summary Statistics, and Intention-to-Treat Analyses Effect Sizes While statistical significance testing can determine whether groups differ on a particular dimension or outcome, effect sizes can better inform us of the magnitude of treatment gains and clinical importance of the findings. The Publication Manual of the American Psychological Association (APA, 2001) identifies the failure to report effect sizes as a ''defect in the design and reporting of research'' (p. 5). It is also important to report confidence intervals for effect sizes, as these intervals evaluate the precision of the estimates and also allow effect sizes to be graphically represented in a more meaningful way (Vacha-Haase & Thompson, 2004) .
Intention-to-treat Analyses
Study authors should aim to conduct intention-to-treat analyses which means including all participants in the final analyses and keeping them in the condition to which they were randomized, even if they dropped out or did not receive the treatment/control designated to that condition. Participants who drop out or do not complete their assigned condition, may be qualitatively different on some domain(s) from participants who completed the protocol as intended. Analyses that are not intentionto-treat may lead to biased treatment effects, making it challenging to determine whether bias stemming from participants not completing the protocol might have influenced the results .
Summary Statistics
One of the primary reasons for exclusion of RCTs in meta-analyses is failing to provide summary statistics (e.g., means, standard deviations) necessary for datapooling. In addition, it is common for studies to provide summary statistics when there are significant differences between groups, but not when differences are nonsignificant. It is critical for authors to provide this information regardless of whether groups are statistically different, in order to prevent biased meta-analytic results favoring treatment effects.
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